Higher levels of brain injury biomarker tau are associated with unfavorable outcomes in patients supported with ECMO following cardiac arrest

Jamie McElrath Schwartz; Derek K Ng; Jennifer Roem; Nikhil Padmanabhan; Daniel Romero; Jessica Joe; Christopher Campbell; George B Sigal; Jacob N Wohlstadter; Allen D Everett; Melania M Bembea

doi:10.1016/j.resplu.2024.100609

Higher levels of brain injury biomarker tau are associated with unfavorable outcomes in patients supported with ECMO following cardiac arrest

Resusc Plus. 2024 Mar 22:18:100609. doi: 10.1016/j.resplu.2024.100609. eCollection 2024 Jun.

Affiliations

¹ Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
² Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
³ Meso Scale Diagnostics, LLC, Rockville, MD, United States.
⁴ Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Abstract

Aim: We sought to determine if higher plasma levels of brain injury biomarkers neurofilament light (NfL), phosphorylated tau 181 (pT181), tau, and ubiquitin C-terminal hydrolase L1 (UCHL1) were associated with unfavorable outcomes in children supported on extracorporeal membrane oxygenation (ECMO) with and without preceding cardiac arrest.

Methods: We conducted a secondary analysis of a two-center prospective observational study of ECMO patients 0-<18 years. Plasma concentrations of NfL, pT181, tau, and UCHL1 were measured on ECMO days 1, 2 and 3. Unfavorable outcome was defined as in-hospital mortality or discharge Pediatric Cerebral Performance Category (PCPC) >2 with decline from baseline PCPC among survivors.

Results: Among 88 children on ECMO, mean tau levels were significantly higher on each of the first three ECMO days in children who underwent extracorporeal cardiopulmonary resuscitation (ECPR) compared to those with non-ECPR cardiac arrest or with no cardiac arrest preceding ECMO. Higher ECMO day 1 tau levels were significantly associated with increased hazard of unfavorable outcome in unadjusted (HR, 1.35, 95% CI 1.09-1.66) and adjusted (HR, 1.42; 95% CI 1.13-1.79) models. Higher levels of NfL or pT181 were not associated with increased hazard for unfavorable outcome in multivariable models. UCHL1 values were outside of detectable limits and thus deferred from analysis.

Conclusions: Levels of tau were significantly associated with increased hazard of death or unfavorable neurologic outcome in unadjusted and adjusted models. Biomarkers of brain injury, particularly tau, may aid in detection of neurologic injury and neuroprognostication in patients on ECMO with and without preceding cardiac arrest.

Keywords: Biomarker; Brain injury; Cardiac arrest; Child; Extracorporeal cardiopulmonary resuscitation; Extracorporeal membrane oxygenation.